2 years ago Lydia, a paediatrician, co-founded Forward Health, a start-up aiming to solve communication in healthcare. In a sector defined by governments and Goliaths, how would a group of junior doctors fare? What chance did a tiny start-up have in a world of dense regulation, opaque decision making and a reputation for killing off tech? The NHS was until recently a desert for digital innovation, but slowly, it seems, oases of progress are beginning to converge, and companies who appeared at the right time, in the right place, are thriving. Forward is only a few chapters into its story, but in this reflection Lydia explores what it took to start something from nothing, and grow an innovation in the healthcare industry.
The healthcare sector is changing to embrace a more proactive patient health management, and the rapid development of sensing technology is opening opportunities for continuous health monitoring. These energy-efficient sensors are following a trend towards miniaturisation for implantable devices, drug delivery devices, epidermic electronic patches, and for ophthalmic or orthodontics applications. In most cases, a solution needs to be provided to power these devices autonomously or wirelessly which requires energy storage devices with long life, high reliability, high energy density, and bio-compatibility.
This presentation will review and compare alternatives for powering medical devices such as conventional and solid-state batteries, and super-capacitors. It will evaluate the requirements for medical sensing devices including their size and shape, lifecycle, cost, safety and biocompatibility, and technical performance. The session will also examine different options for powering the devices autonomously and wirelessly through induction or harvested energy.
Universal healthcare, free at the point of care, has been delivered for 70+ years by the NHS. It’s threatened by what Sir Bruce Keogh describes as the ‘triple pincer’: ‘escalating demand, escalating costs and restrained resources’.
In this session, Hannah Rose will discuss the need and opportunity for innovation to uphold NHS principles such as patient-centered care, cost-effectiveness and universality. Innovations with such potential include those from femtech, digital therapeutics and AI-driven models in prevention and early response. Join Hannah Rose, as she shares insights from across the Journalista community and beyond.
Alder Hey Children’s Hospital in Liverpool has embarked on an ambitious program to harness emerging technologies to create a ‘Living Hospital’. Combining Artificial intelligence, sensors and holistic care we aim to make the building be as important part of the care as the medical professionals within it.
In a ground-breaking collaboration between the Hartree Centre and Alder Hey Children’s Hospital, we are helping to build the UK’s first cognitive assistant for patients ‘Ask Oli’. The technology we are developing will help to revolutionise personalised medicine, putting the patient at the centre of their care in a way that has never before been possible.
The NIHR is unique. It provides a gateway for you to carry out your clinical research and technology evaluation in the NHS - the largest integrated healthcare system in the world.
We work with a diverse range of industry sectors, including diagnostics, medical technology and biopharmaceutical, as well as with associated industries such as digital, design and artificial intelligence.
The NIHR Office for Clinical Research Infrastructure (NOCRI) can support you in the translation and adoption of your products into the NHS. We do this by connecting you to world-leading expertise and organisations so to help build up the evidence required, no matter where you are within your product development pathway. Our team does this by signposting into the NIHR and wider UK research ecosystem, including regulatory and funding bodies, as well as facilitate the setup and management of collaborations.
The NOCRI’s Business Development Team is here to help you navigate the NIHR, so that you can access the support you need. And best of all...this support is available for free.
Find out how new, and emerging, 3D design and fabrication technologies are now combining to create significant opportunities in the area of healthcare product design and manufacture. This presentation will show how they are influencing the disability sector with the promise of creating efficient, unique solutions that can satisfy needs on a very individual basis. One example of this is the use of Generative Design, a brand-new design technique for creating optimised designs, which has been applied to a wheelchair to explore how the future of the sector might be influenced by one of these new methods. This study was undertaken as part of a wider project that investigated and developed the potential of using the latest digital design, collaboration and digital fabrication techniques for creating and producing more easily customisable wheelchairs. The project’s aims were to offer the user a wider range of capabilities, and more choice over the form and function of their wheelchair.
All amputees have different stories to tell, share various interests and have distinct ways of expressing themselves. Glaze Prosthetics addresses their users’ diverse needs by creating innovative upper limb systems. The replaceable arms can interchange in less than three seconds and come in stylish shapes and colours. This presentation will evaluate how Glaze Prosthetics uses SLS technology to develop their customisable devices and how they revolutionise the prosthetics industry.
The beginning of 2019 saw the launch of the NHS’s Long-Term Plan. We now know what the shape of the service will look like over the next decade –and can make some predictions about what it will mean for MedTech.
The Plan will influence the UK MedTech market in several ways –firstly, in the customer base, with large-scale integration leading to joint commissioning, mergers, new pathways and pooled budgets.
Then there’s the commitment to the Getting it Right First Time (GIRFT) programme –which will have an impact on surgical technique, staffing, product acquisition and treatment setting –with new integrated care systems expected to adhere to it.
The Future Operating Model for procurement is also enshrined in the Plan, with the so-called procurement towers now set towards controlling up to 80 per cent of NHS purchasing.
Finally, the Plan suggests that NICE will be encouraged to place devices on an equal footing with drugs, with speedier evaluation and a MedTech funding mandate. With a refreshed new focus on technological innovation, is the Plan an opportunity for the industry?
In a time when technology enhancements are often centred around connectivity to the internet and networks, cyber security in medical devices is becoming increasingly paramount. The global WannaCry attack highlights this as the highest profile cyber attack in recent times, infecting c200,000 computers across 150 countries. The Department for Health reported the attack cost the NHS £92m and it is estimated that over 1000 pieces of medical diagnostic equipment were infected – numbers could have been much higher if devices were not disconnected when they were.
As medical device designers and manufacturers, it is your responsibility to manage and mitigate the threat of a cyber attack throughout the entire product lifecycle.
Alastair Walker, owner of functional safety and regulatory compliance consultancy - Lorit Consultancy, will highlight the importance of cyber security in medical devices, what key guidance is available from the industry through NIST, AAMI and the FDA, and importantly, he will advise on how to keep your cyber security risk management process manageable!
Much has been written about the impact of Brexit and what this means for all of us as patients in the UK. Whilst its long-term impact on the country remains to be seen, an immediate effect has been felt in the supply chain of HealthTech products. With analysis suggesting over 60% of imports into the NHS come directly from the European Union, companies have spent much of the past two years on contingency planning. Complex, international supply chains mean that products can move across the UK / EU border many times in their lifecycle, for sourcing, assembly, packaging and sterilisation. The result of this highly efficient system means many products are supplied into the NHS “next day” from Europe, presenting a significant challenge in the event of border disruptions. Join ABHI, the UK’s leading HealthTech trade association, as their External Affairs Manager, Eleanor Charsley guides delegates on the impact of this critical time in the industry’s history.
This talk will cover the essential aspects of protecting innovations, building a portfolio of intellectual property and using this as a strategic asset to defend core technology, secure funding, build revenue and form successful partnerships in the medical field. The session will cover the US and European markets, and highlight the opportunities and threats that patents represent in these territories.
3D printing has been forecast to revolutionise the healthcare sector; this technology can enable the production of personalised medicines of virtually any shape, size, dosage and drug combinations, directly at the point of care. In 2016, the first 3D printed tablet (Spritam®) was approved by the FDA, creating the need for the wider healthcare community to understand this technology and its future implications to clinical practice. This presentation will cover the latest, cutting-edge research in 3D printing of personalised medicines, discussing the various technologies and how such platforms will revolutionise pharmaceutical manufacture across healthcare.
At this Pharma Insight Briefing session, Sai Shankar, Director Business Development Connected Devices will discuss Aptar Pharma’s approach to building the Digital Medicine ecosystem for connected drug delivery devices across therapeutic areas.
To deliver on the promise of digital medicine to improve patient outcomes, it is important to look at the building blocks of such an eco-system. This starts with understanding the challenges faced by patients while taking their medications, their interactions with the drug delivery systems and how design of connected devices can be seamlessly integrated to improve adherence.
This patient-centric design approach will determine the type of data that should be generated from the connected devices, which in turn will drive the type of technology that should be adopted.
These design decisions will also impact the electronics design architecture, stacking of different technology options and cross-platform interoperability. Complementing the device design should be a proven high quality manufacturing setup that has a secure supply chain for electronics and plastic components. The last mile of building the ecosystem is the successful pairing of the data from devices to the digital medicine platform.
This panel discussion will ask women working with plastics in the modern healthcare industries what challenges and opportunities they face in 2019. It will ask whether there is enough visibility of role models to encourage more women into the sector, and look at the benefits of mentoring.
We’ll ask if gender balance and equality is better in healthcare plastics than the wider plastics industry, and, if not, invite suggestions for improvements. The panel will discuss how innovation is driving the healthcare industries and how plastics materials and technologies are enablers for this.
Sandvik Material Technology developed a new format of Sandvik Nanoflex and conducted several tests to produce micro-tubes with this material from welded strips.
The welded tubes produced with the Nanoflex offer excellent performance as the material consists of nanoparticles and quasicrystal structure. It is very easy to work with, when compared to a standard austenitic material, has a very high modulus of elasticity and is very tensile (over 2000 MPa - against 800-900 MPa reached with the standard tubes in 304-316).
Sandvik Nanoflex is an alternative to high-cost materials like titanium or MP35N with better mechanical performances. The tubes are also very safe thanks to the new structure and consists of high ductility. Despite the tensile level of 2300 MPa, they can be bend without breaking.
This presentation will evaluate the capabilities and the performance of Sandvik Nanoflex. It will also examine the ways to achieve a perfect tube or micro-tube thanks to the new structure of the material.
A great place to engage with innovators and stakeholders across the innovation landscape.
A well organised exhibition that generated plenty of foot fall. We would happily support Med-Tech Innovation Expo again, and look forward to the relocation to the NEC.
We met several companies who gave us interesting and knowledgeable information which will assist us in our future product and manufacturing decisions.
Great show for presenting our company to the medical device marketplace we had plenty of interesting conversations which am i sure will convert into business opportunities.